Created at	Source	Raw Value	Validated value
Nov. 26, 2021, 10:30 p.m.	oms	Not giving written informed consent <br/ >ALT/AST >5 times the upper limit of normal. <br/ >Stage 4 severe chronic kidney disease or requiring dialysis (i.e. eGFR <30). <br/ >Pregnant or breast feeding. <br/ >Allergy to any study medication. <br/ >Severe co-morbidity as per investigatorâ??s assessment <br/ >Comorbid condition like myocardial infarction or heart failure within 90 days of recruitment. <br/ >Prolonged QT interval ( >450 ms) <br/ >Any other concomitant therapeutic trial <br/ >Weight <15 kg <br/ >	Not giving written informed consent <br/ >ALT/AST >5 times the upper limit of normal. <br/ >Stage 4 severe chronic kidney disease or requiring dialysis (i.e. eGFR <30). <br/ >Pregnant or breast feeding. <br/ >Allergy to any study medication. <br/ >Severe co-morbidity as per investigatorâ??s assessment <br/ >Comorbid condition like myocardial infarction or heart failure within 90 days of recruitment. <br/ >Prolonged QT interval ( >450 ms) <br/ >Any other concomitant therapeutic trial <br/ >Weight <15 kg <br/ >
Nov. 13, 2021, 5:33 p.m.	oms	N/A	N/A
Oct. 26, 2020, 8:29 a.m.	oms	Not giving written informed consent <br/ >ALT/AST >5 times the upper limit of normal. <br/ >Stage 4 severe chronic kidney disease or requiring dialysis (i.e. eGFR <30). <br/ >Pregnant or breast feeding. <br/ >Allergy to any study medication. <br/ >Severe co-morbidity as per investigatorâ??s assessment <br/ >Comorbid condition like myocardial infarction or heart failure within 90 days of recruitment. <br/ >Prolonged QT interval ( >450 ms) <br/ >Any other concomitant therapeutic trial <br/ >Weight <15 kg <br/ >	Not giving written informed consent <br/ >ALT/AST >5 times the upper limit of normal. <br/ >Stage 4 severe chronic kidney disease or requiring dialysis (i.e. eGFR <30). <br/ >Pregnant or breast feeding. <br/ >Allergy to any study medication. <br/ >Severe co-morbidity as per investigatorâ??s assessment <br/ >Comorbid condition like myocardial infarction or heart failure within 90 days of recruitment. <br/ >Prolonged QT interval ( >450 ms) <br/ >Any other concomitant therapeutic trial <br/ >Weight <15 kg <br/ >